Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III TrialPaul E. Goss, Lois E. Shepherd, James N. Ingle et al.|Journal of Clinical Oncology|2013Cited by 261
Abstract P1-07-06: Adjunctive statistical standardization of quantitated adjuvant HER2 and very low statistically standardized HER2 in CCTG MA.27Judith-Anne Chapman, Karen J. Taylor, Tammy Piper et al.|Clinical Cancer Research|2025Cited by 0